Targeting activated mineralocorticoid receptor: Occam's razor revisited.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22935878.
- Also identified by DOI 10.1038/ki.2012.157.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Activation of mineralocorticoid receptors (MRs) classically has been associated with electrolyte transport, but we now know that MR activation can also lead to tissue inflammation and fibrosis. Aldosterone consistently activates MR, but under selected circumstances, endogenous glucocorticoids such as cortisol and corticosterone can also trigger MR. Tissue-specific safeguards such as the enzyme 11β-hydroxysteroid dehydrogenase limit glucocorticoid-induced MR activation, while the presence of reactive oxygen species may enhance the ability for glucocorticoid-induced MR activation even in the absence of aldosterone.
Medical subject headings
- Aldosterone
- Angiotensin II
- Heart Diseases
- Kidney Diseases
- Mineralocorticoid Receptor Antagonists
- Receptors, Mineralocorticoid
- Spironolactone
- Vascular Diseases